Trial Kicks Off Over Sanofi's IP Claims Over Generic Multaq
A three-day bench trial over pharmaceutical company Sanofi SA's claims that several drugmakers infringed its patents for heart rhythm medication Multaq by filing regulatory applications for generic versions kicked off Tuesday...To view the full article, register now.
Already a subscriber? Click here to view full article